| Category | BioTech |
| Phone | 314-812-8151 |
| Employees | |
| Founded | 2002 |
| TOTAL | $6M |
| FUNDING TOTAL | $6M |
| Series B, 8/05 Burrill & Company Redmont Venture Partners Prolog Ventures Harris & Harris Group | $6M |
Chlorogen a biopharmaceutical company, engages in the development and manufacture of proteins for human therapy. The company, through its chloroplast transformation technology (CTT), offers plant made drugs for the treatment and prevention of human diseases, as well as for treatment of women’s reproductive cancers. Its products include therapeutic proteins in tobacco that are made using chloroplast transformation technology. The chloroplast transformation technology facilitates hyper-expression of recombinant proteins in tobacco chloroplasts. The company offers its chloroplast-tobacco platform for commercial use in food and agriculture. Chlorogen, Inc. was founded in 2002 and is based in St. Louis, Missouri.
